Jenburkt is the second in India to introduce Favipiravir for the treatment of COVID-19
The Favipiravir-200 mg tablets are recommended for the treatment of mild to moderate COVID-19 patients
Price feed provided by www.nseindia.com
and www.bseindia.com value
addition by www.accordfintech.com.
Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.